The Centers for Medicare & Medicaid Services (CMS) is developing a pilot program that could change the landscape of obesity ...

Trump demands U.S. drug prices match lowest international rates for some or face executive action. This article originally ...

Medicare is expanding its drug price negotiation program to include 15 more medications, including popular drugs like Ozempic.

Medicare Advantage usage trends reveal slight declines in 2023, highlighting critical insights for policymakers amid rising ...

Eli Lilly's stock is lagging the S&P 500 since April, potentially allowing a catch-up trade if results impress. Medicare may ...

GLP‑1 receptor agonists are widely recognized for aiding weight loss and controlling blood sugar, but access remains limited — especially for Medicare and Medicaid patients. That might change with a ...

President Donald Trump says pharma tariffs could go as high as 250%. UBS downgrades Novo Nordisk stock to neutral and lowers ...

The Center for Medicare and Medicaid Innovation may introduce a five-year pilot model to expand access to weight loss drugs, ...

The Texas governor is threatening Democrats who don’t show up to the Capitol to vote on his gerrymandered maps.

The GOP’s official X page seems to have used a doctored photo of JD Vance in their birthday post for him, slimming the vice ...

President Trump escalated pressure on the pharmaceutical industry last week by sending letters to 17 major drug companies ...

Earlier this year, the Centers for Medicare and Medicaid Services scrapped a previous proposal, from the Biden administration ...